PubMed:32841688
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 1382-1393 | Body_part | denotes | bone marrow | http://purl.org/sig/ont/fma/fma9608 |
| T2 | 1437-1446 | Body_part | denotes | platelets | http://purl.org/sig/ont/fma/fma62851 |
| T3 | 1448-1458 | Body_part | denotes | leukocytes | http://purl.org/sig/ont/fma/fma62852 |
| T4 | 1464-1474 | Body_part | denotes | hemoglobin | http://purl.org/sig/ont/fma/fma62293 |
| T5 | 1739-1750 | Body_part | denotes | bone marrow | http://purl.org/sig/ont/fma/fma9608 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 1382-1393 | Body_part | denotes | bone marrow | http://purl.obolibrary.org/obo/UBERON_0002371 |
| T2 | 1739-1750 | Body_part | denotes | bone marrow | http://purl.obolibrary.org/obo/UBERON_0002371 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 54-62 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T2 | 63-74 | Disease | denotes | pneumonitis | http://purl.obolibrary.org/obo/MONDO_0043905 |
| T3 | 261-269 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T4 | 513-521 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T5 | 522-533 | Disease | denotes | pneumonitis | http://purl.obolibrary.org/obo/MONDO_0043905 |
| T6 | 789-807 | Disease | denotes | Pulmonary fibrosis | http://purl.obolibrary.org/obo/MONDO_0002771 |
| T7 | 937-955 | Disease | denotes | pulmonary fibrosis | http://purl.obolibrary.org/obo/MONDO_0002771 |
| T8 | 1091-1103 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
| T9 | 1117-1125 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
| T10 | 1243-1251 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T11 | 1252-1263 | Disease | denotes | pneumonitis | http://purl.obolibrary.org/obo/MONDO_0043905 |
| T12 | 1334-1346 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
| T13 | 1618-1626 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T14 | 1627-1638 | Disease | denotes | pneumonitis | http://purl.obolibrary.org/obo/MONDO_0043905 |
| T15 | 1657-1675 | Disease | denotes | pulmonary fibrosis | http://purl.obolibrary.org/obo/MONDO_0002771 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 78-79 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T2 | 694-695 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T3 | 735-736 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T4 | 782-783 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T5 | 973-978 | http://purl.obolibrary.org/obo/UBERON_0003101 | denotes | males |
| T6 | 973-978 | http://www.ebi.ac.uk/efo/EFO_0000970 | denotes | males |
| T7 | 1026-1032 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
| T8 | 1233-1234 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T9 | 1307-1308 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T10 | 1382-1386 | http://purl.obolibrary.org/obo/UBERON_0002481 | denotes | bone |
| T11 | 1410-1411 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T12 | 1562-1563 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T13 | 1592-1593 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T14 | 1697-1702 | http://purl.obolibrary.org/obo/UBERON_0003101 | denotes | males |
| T15 | 1697-1702 | http://www.ebi.ac.uk/efo/EFO_0000970 | denotes | males |
| T16 | 1739-1743 | http://purl.obolibrary.org/obo/UBERON_0002481 | denotes | bone |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 641-650 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T2 | 653-662 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
| T3 | 664-671 | Chemical | denotes | Kaletra | http://purl.obolibrary.org/obo/CHEBI_145924 |
| T4 | 703-712 | Chemical | denotes | darunavir | http://purl.obolibrary.org/obo/CHEBI_367163 |
| T5 | 715-724 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
| T6 | 1464-1474 | Chemical | denotes | hemoglobin | http://purl.obolibrary.org/obo/CHEBI_35143 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 789-807 | Phenotype | denotes | Pulmonary fibrosis | http://purl.obolibrary.org/obo/HP_0002206 |
| T2 | 937-955 | Phenotype | denotes | pulmonary fibrosis | http://purl.obolibrary.org/obo/HP_0002206 |
| T3 | 1091-1103 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
| T4 | 1179-1197 | Phenotype | denotes | reversed halo sign | http://purl.obolibrary.org/obo/HP_0032983 |
| T5 | 1527-1545 | Phenotype | denotes | reversed halo sign | http://purl.obolibrary.org/obo/HP_0032983 |
| T6 | 1657-1675 | Phenotype | denotes | pulmonary fibrosis | http://purl.obolibrary.org/obo/HP_0002206 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1334-1346 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-101 | Sentence | denotes | First report on clinical and radiological features of COVID-19 pneumonitis in a Caucasian population: |
| T2 | 102-140 | Sentence | denotes | Factors predicting fibrotic evolution. |
| T3 | 141-152 | Sentence | denotes | BACKGROUND: |
| T4 | 153-270 | Sentence | denotes | At the end of February, the Lombardy region (Northern Italy) was involved in the pandemic spread of the new COVID-19. |
| T5 | 271-420 | Sentence | denotes | We here summarize the clinical and radiological characteristics of 90 confirmed cases and analyze their role in predicting the evolution of fibrosis. |
| T6 | 421-429 | Sentence | denotes | METHODS: |
| T7 | 430-534 | Sentence | denotes | We retrospectively analyzed the clinical and radiological data of 90 patients with COVID-19 pneumonitis. |
| T8 | 535-788 | Sentence | denotes | All subjects underwent an HRCT study on the day of admission and eight weeks later, and were treated with lopinavir + ritonavir (Kaletra) 400/100 mg two times a day or darunavir + ritonavir two times a day, and Hydroxychloroquine 200 mg two times a day. |
| T9 | 789-895 | Sentence | denotes | Pulmonary fibrosis was defined according to the Fleischner Society glossary of terms for thoracic imaging. |
| T10 | 896-904 | Sentence | denotes | RESULTS: |
| T11 | 905-964 | Sentence | denotes | Twenty-three patients developed pulmonary fibrosis (25.5%): |
| T12 | 965-1007 | Sentence | denotes | 15 were males, whose mean age was 75 ± 15. |
| T13 | 1008-1134 | Sentence | denotes | The majority were active smokers (60.8%) and had comorbidities (78.2%), above all, hypertension (47.8%), and diabetes (34.7%). |
| T14 | 1135-1272 | Sentence | denotes | Interestingly, in our series of cases, the "reversed halo sign" is frequent (63%) and seems to be a typical COVID-19 pneumonitis pattern. |
| T15 | 1273-1475 | Sentence | denotes | The patients showing fibrosis had a higher grade of systemic inflammation (ESR and PCR) and appeared to have bone marrow inhibition with a significant reduction in platelets, leukocytes, and hemoglobin. |
| T16 | 1476-1488 | Sentence | denotes | CONCLUSIONS: |
| T17 | 1489-1639 | Sentence | denotes | To conclude, our data showed that the reversed halo sign associated with a ground-glass pattern may be a typical HRCT pattern of COVID-19 pneumonitis. |
| T18 | 1640-1763 | Sentence | denotes | The evolution to pulmonary fibrosis is frequent in older males and patients with comorbidities and bone marrow involvement. |
| T1 | 0-101 | Sentence | denotes | First report on clinical and radiological features of COVID-19 pneumonitis in a Caucasian population: |
| T2 | 102-140 | Sentence | denotes | Factors predicting fibrotic evolution. |
| T3 | 141-152 | Sentence | denotes | BACKGROUND: |
| T4 | 153-270 | Sentence | denotes | At the end of February, the Lombardy region (Northern Italy) was involved in the pandemic spread of the new COVID-19. |
| T5 | 271-420 | Sentence | denotes | We here summarize the clinical and radiological characteristics of 90 confirmed cases and analyze their role in predicting the evolution of fibrosis. |
| T6 | 421-429 | Sentence | denotes | METHODS: |
| T7 | 430-534 | Sentence | denotes | We retrospectively analyzed the clinical and radiological data of 90 patients with COVID-19 pneumonitis. |
| T8 | 535-788 | Sentence | denotes | All subjects underwent an HRCT study on the day of admission and eight weeks later, and were treated with lopinavir + ritonavir (Kaletra) 400/100 mg two times a day or darunavir + ritonavir two times a day, and Hydroxychloroquine 200 mg two times a day. |
| T9 | 789-895 | Sentence | denotes | Pulmonary fibrosis was defined according to the Fleischner Society glossary of terms for thoracic imaging. |
| T10 | 896-904 | Sentence | denotes | RESULTS: |
| T11 | 905-964 | Sentence | denotes | Twenty-three patients developed pulmonary fibrosis (25.5%): |
| T12 | 965-1007 | Sentence | denotes | 15 were males, whose mean age was 75 ± 15. |
| T13 | 1008-1134 | Sentence | denotes | The majority were active smokers (60.8%) and had comorbidities (78.2%), above all, hypertension (47.8%), and diabetes (34.7%). |
| T14 | 1135-1272 | Sentence | denotes | Interestingly, in our series of cases, the "reversed halo sign" is frequent (63%) and seems to be a typical COVID-19 pneumonitis pattern. |
| T15 | 1273-1475 | Sentence | denotes | The patients showing fibrosis had a higher grade of systemic inflammation (ESR and PCR) and appeared to have bone marrow inhibition with a significant reduction in platelets, leukocytes, and hemoglobin. |
| T16 | 1476-1488 | Sentence | denotes | CONCLUSIONS: |
| T17 | 1489-1639 | Sentence | denotes | To conclude, our data showed that the reversed halo sign associated with a ground-glass pattern may be a typical HRCT pattern of COVID-19 pneumonitis. |
| T18 | 1640-1763 | Sentence | denotes | The evolution to pulmonary fibrosis is frequent in older males and patients with comorbidities and bone marrow involvement. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1 | 54-74 | Disease | denotes | COVID-19 pneumonitis | MESH:C000657245 |
| 27 | 261-269 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 28 | 411-419 | Disease | denotes | fibrosis | MESH:D005355 |
| 29 | 499-507 | Species | denotes | patients | Tax:9606 |
| 30 | 513-521 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 31 | 522-533 | Disease | denotes | pneumonitis | MESH:D011014 |
| 32 | 641-662 | Chemical | denotes | lopinavir + ritonavir | MESH:C558899 |
| 33 | 664-671 | Chemical | denotes | Kaletra | MESH:C558899 |
| 34 | 703-712 | Chemical | denotes | darunavir | MESH:D000069454 |
| 35 | 715-724 | Chemical | denotes | ritonavir | MESH:D019438 |
| 36 | 746-764 | Chemical | denotes | Hydroxychloroquine | MESH:D006886 |
| 37 | 789-807 | Disease | denotes | Pulmonary fibrosis | MESH:D011658 |
| 38 | 918-926 | Species | denotes | patients | Tax:9606 |
| 39 | 937-955 | Disease | denotes | pulmonary fibrosis | MESH:D011658 |
| 40 | 1091-1103 | Disease | denotes | hypertension | MESH:D006973 |
| 41 | 1117-1125 | Disease | denotes | diabetes | MESH:D003920 |
| 42 | 1618-1626 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 43 | 1627-1638 | Disease | denotes | pneumonitis | MESH:D011014 |
| 49 | 1657-1675 | Disease | denotes | pulmonary fibrosis | MESH:D011658 |
| 50 | 1707-1715 | Species | denotes | patients | Tax:9606 |
| 51 | 1739-1762 | Disease | denotes | bone marrow involvement | MESH:D001855 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-101 | Sentence | denotes | First report on clinical and radiological features of COVID-19 pneumonitis in a Caucasian population: |
| T2 | 102-140 | Sentence | denotes | Factors predicting fibrotic evolution. |
| T3 | 141-152 | Sentence | denotes | BACKGROUND: |
| T4 | 153-270 | Sentence | denotes | At the end of February, the Lombardy region (Northern Italy) was involved in the pandemic spread of the new COVID-19. |
| T5 | 271-420 | Sentence | denotes | We here summarize the clinical and radiological characteristics of 90 confirmed cases and analyze their role in predicting the evolution of fibrosis. |
| T6 | 421-429 | Sentence | denotes | METHODS: |
| T7 | 430-534 | Sentence | denotes | We retrospectively analyzed the clinical and radiological data of 90 patients with COVID-19 pneumonitis. |
| T8 | 535-788 | Sentence | denotes | All subjects underwent an HRCT study on the day of admission and eight weeks later, and were treated with lopinavir + ritonavir (Kaletra) 400/100 mg two times a day or darunavir + ritonavir two times a day, and Hydroxychloroquine 200 mg two times a day. |
| T9 | 789-895 | Sentence | denotes | Pulmonary fibrosis was defined according to the Fleischner Society glossary of terms for thoracic imaging. |
| T10 | 896-904 | Sentence | denotes | RESULTS: |
| T11 | 905-964 | Sentence | denotes | Twenty-three patients developed pulmonary fibrosis (25.5%): |
| T12 | 965-1007 | Sentence | denotes | 15 were males, whose mean age was 75 ± 15. |
| T13 | 1008-1134 | Sentence | denotes | The majority were active smokers (60.8%) and had comorbidities (78.2%), above all, hypertension (47.8%), and diabetes (34.7%). |
| T14 | 1135-1272 | Sentence | denotes | Interestingly, in our series of cases, the "reversed halo sign" is frequent (63%) and seems to be a typical COVID-19 pneumonitis pattern. |
| T15 | 1273-1475 | Sentence | denotes | The patients showing fibrosis had a higher grade of systemic inflammation (ESR and PCR) and appeared to have bone marrow inhibition with a significant reduction in platelets, leukocytes, and hemoglobin. |
| T16 | 1476-1488 | Sentence | denotes | CONCLUSIONS: |
| T17 | 1489-1639 | Sentence | denotes | To conclude, our data showed that the reversed halo sign associated with a ground-glass pattern may be a typical HRCT pattern of COVID-19 pneumonitis. |
| T18 | 1640-1763 | Sentence | denotes | The evolution to pulmonary fibrosis is frequent in older males and patients with comorbidities and bone marrow involvement. |
hydroxychloroquine
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 789-807 | Phenotype | denotes | Pulmonary fibrosis | http://purl.obolibrary.org/obo/HP_0002206 |
| T2 | 937-955 | Phenotype | denotes | pulmonary fibrosis | http://purl.obolibrary.org/obo/HP_0002206 |
| T3 | 1091-1103 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
| T4 | 1179-1197 | Phenotype | denotes | reversed halo sign | http://purl.obolibrary.org/obo/HP_0032983 |
| T5 | 1527-1545 | Phenotype | denotes | reversed halo sign | http://purl.obolibrary.org/obo/HP_0032983 |
| T6 | 1657-1675 | Phenotype | denotes | pulmonary fibrosis | http://purl.obolibrary.org/obo/HP_0002206 |